Is this the real time for genomics?

Genomics

Volumn 103, Issue 2-3, 2014, Pages 177-182

  Guarnaccia, Maria ^a   Gentile, Giulia ^a   Alessi, Enrico ^b   Schneider, Claudio ^c   Petralia, Salvatore ^b   Cavallaro, Sebastiano ^a  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b STMICROELECTRONICS   (Italy)

^c National Laboratory of the Interuniversity Consortium for Biotechnology   (Italy)

Author keywords

Diagnostics; Genome based tests; Lab on Chip; Next generation sequencing; Point of Care; Real time microarray

Indexed keywords

BIOCHEMICAL EQUIPMENT; DNA MICROARRAY; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HYBRIDIZATION; IMAGE ANALYSIS; IN CHECK LAB ON CHIP PLATFORM; INFINITY SYSTEM; LAB ON A CHIP; MEASUREMENT ACCURACY; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVIEW; RHEONIX CARD PLATFORM; VERIGENE SYSTEM; ANIMAL; DEVICES; POLYMERASE CHAIN REACTION; PROCEDURES; TRENDS;

ANIMALS; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LAB-ON-A-CHIP DEVICES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 84898031539     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2014.02.003     Document Type: Review

References (68)

1. Benson D.A., Cavanaugh M., Clark K., Karsch-Mizrachi I., Lipman D.J., Ostell J., Sayers E.W. GenBank. Nucleic Acids Res. 2013, 41:D36-D42.
2. Hamosh A., Scott A.F., Amberger J.S., Bocchini C.A., McKusick V.A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005, 33:D514-D517.
3. McKusick V.A. Mendelian Inheritance in Man and its online version, OMIM. Am. J. Hum. Genet. 2007, 80:588-604.
4. Bamshad M.J., Shendure J.A., Valle D., Hamosh A., Lupski J.R., Gibbs R.A., Boerwinkle E., Lifton R.P., Gerstein M., Gunel M., Mane S., Nickerson D.A., G.on behalf of the Centers for Mendelian The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions. Am. J. Med. Genet. A 2012, 158A:1523-1525.
5. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Sayers E.W. GenBank. Nucleic Acids Res. 2010, 38:D46-D51.
6. Alminana C., Fazeli A. Exploring the application of high-throughput genomics technologies in the field of maternal-embryo communication. Theriogenology 2012, 77:717-737.
7. Lee C.Y. Common applications of next-generation sequencing technologies in genomic research. Trans. Cancer Res. 2013, 2:33-45.
8. Meldrum C., Doyle M.A., Tothill R.W. Next-generation sequencing for cancer diagnostics: a practical perspective. Clin. Biochem. Rev. Aust. Assoc. Clin. Biochem. 2011, 32:177-195.
9. Ozsolak F., Milos P.M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 2011, 12:87-98.
10. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10:57-63.
11. Sassolas A., Leca-Bouvier B.D., Blum L.J. DNA biosensors and microarrays. Chem. Rev. 2008, 108:109-139.
12. Mello-Coelho V., Hess K.L. A conceptual and practical overview of cDNA microarray technology: implications for basic and clinical sciences. Braz. J. Med. Biol. Res. 2005, 38:1543-1552.
13. Beltrami A.P., Cesselli D., Bergamin N., Marcon P., Rigo S., Puppato E., D'Aurizio F., Verardo R., Piazza S., Pignatelli A., Poz A., Baccarani U., Damiani D., Fanin R., Mariuzzi L., Finato N., Masolini P., Burelli S., Belluzzi O., Schneider C., Beltrami C.A. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007, 110:3438-3446.
14. De Cecco L., Marchionni L., Gariboldi M., Reid J.F., Lagonigro M.S., Caramuta S., Ferrario C., Bussani E., Mezzanzanica D., Turatti F., Delia D., Daidone M.G., Oggionni M., Bertuletti N., Ditto A., Raspagliesi F., Pilotti S., Pierotti M.A., Canevari S., Schneider C. Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2. Oncogene 2004, 23:8171-8183.
15. Cesselli D., Beltrami A.P., D'Aurizio F., Marcon P., Bergamin N., Toffoletto B., Pandolfi M., Puppato E., Marino L., Signore S., Livi U., Verardo R., Piazza S., Marchionni L., Fiorini C., Schneider C., Hosoda T., Rota M., Kajstura J., Anversa P., Beltrami C.A., Leri A. Effects of age and heart failure on human cardiac stem cell function. Am. J. Pathol. 2011, 179:349-366.
16. Cesselli D., Beltrami A.P., Rigo S., Bergamin N., D'Aurizio F., Verardo R., Piazza S., Klaric E., Fanin R., Toffoletto B., Marzinotto S., Mariuzzi L., Finato N., Pandolfi M., Leri A., Schneider C., Beltrami C.A., Anversa P. Multipotent progenitor cells are present in human peripheral blood. Circ. Res. 2009, 104:1225-1234.
17. Girardini J.E., Napoli M., Piazza S., Rustighi A., Marotta C., Radaelli E., Capaci V., Jordan L., Quinlan P., Thompson A., Mano M., Rosato A., Crook T., Scanziani E., Means A.R., Lozano G., Schneider C., Del Sal G. A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 2011, 20:79-91.
18. Cavallaro S., Schreurs B.G., Zhao W., D'Agata V., Alkon D.L. Gene expression profiles during long-term memory consolidation. Eur. J. Neurosci. 2001, 13:1809-1815.
19. Cavallaro S., Paratore S., de Snoo F., Salomone E., Villari L., Buscarino C., Ferraù F., Banna G., Furci M., Strazzanti A., Cunsolo R., Pezzino S., Gangi S., Basile F. Genomic analysis: toward a new approach in breast cancer management. Crit. Rev. Oncol. Hematol. 2012, 81:207-223.
20. Lederer C.W., Torrisi A., Pantelidou M., Santama N., Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 2007, 8:26.
21. Paratore S., Parenti R., Torrisi A., Copani A., Cicirata F., Cavallaro S. Genomic profiling of cortical neurons following exposure to beta-amyloid. Genomics 2006, 88:468-479.
22. Paratore S., Pezzino S., Cavallaro S. Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways. Curr. Genomics 2012, 13:321-333.
23. Barrett T., Wilhite S.E., Ledoux P., Evangelista C., Kim I.F., Tomashevsky M., Marshall K.A., Phillippy K.H., Sherman P.M., Holko M., Yefanov A., Lee H., Zhang N., Robertson C.L., Serova N., Davis S., Soboleva A. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013, 41:D991-D995.
24. van de Vijver M.J., He Y.D., van 't Veer L.J., Dai H., Hart A.A.M., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., Witteveen A., Glas A., Delahaye L., van der Velde T., Bartelink H., Rodenhuis S., Rutgers E.T., Friend S.H., Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002, 347:1999-2009.
25. Li X., Quigg R.J., Zhou J., Gu W., Nagesh Rao P., Reed E.F. Clinical utility of microarrays: current status, existing challenges and future outlook. Curr. Genomics 2008, 9:466-474.
26. Lababidi S. Challenges in DNA microarray studies from the regulatory perspective. J. Biopharm. Stat. 2008, 18:183-202.
27. Dumur C.I., Fuller C.E., Blevins T.L., Schaum J.C., Wilkinson D.S., Garrett C.T., Powers C.N. Clinical verification of the performance of the pathwork tissue of origin test: utility and limitations. Am. J. Clin. Pathol. 2011, 136:924-933.
28. Dumur C.I., Lyons-Weiler M., Sciulli C., Garrett C.T., Schrijver I., Holley T.K., Rodriguez-Paris J., Pollack J.R., Zehnder J.L., Price M., Hagenkord J.M., Rigl C.T., Buturovic L.J., Anderson G.G., Monzon F.A. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J. Mol. Diagn. 2008, 10:67-77.
29. Wu L., Williams P.M., Koch W. Clinical applications of microarray-based diagnostic tests. BioTechniques 2005, 39:S577-S582.
30. Rebsamen M.C., Desmeules J., Daali Y., Chiappe A., Diemand A., Rey C., Chabert J., Dayer P., Hochstrasser D., Rossier M.F. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction. Pharmacogenomics J. 2009, 9:34-41.
31. Jain K.K. Applications of AmpliChip CYP450. Mol. Diagn. 2005, 9:119-127.
32. Timlin J.A. Scanning microarrays: current methods and future directions. Methods Enzymol. 2006, 411:79-98.
33. Auer H., Lyianarachchi S., Newsom D., Klisovic M.I., Marcucci u., Kornacker K. Chipping away at the chip bias: RNA degradation in microarray analysis. Nat. Genet. 2003, 35:292-293.
34. Draghici S., Khatri P., Eklund A.C., Szallasi Z. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet. 2006, 22:101-109.
35. Livshits M.A., Mirzabekov A.D. Theoretical analysis of the kinetics of DNA hybridization with gel-immobilized oligonucleotides. Biophys. J. 1996, 71:2795-2801.
36. Dai H., Meyer M., Stepaniants S., Ziman M., Stoughton R. Use of hybridization kinetics for differentiating specific from non-specific binding to oligonucleotide microarrays. Nucleic Acids Res. 2002, 30:e86.
37. Held G.A., Grinstein G., Tu Y. Relationship between gene expression and observed intensities in DNA microarrays-a modeling study. Nucleic Acids Res. 2006, 34:e70.
38. Tezak Z., Ranamukhaarachchi D., Russek-Cohen E., Gutman S.I. FDA perspectives on potential microarray-based clinical diagnostics. Hum. Genomics 2006, 2:236-243.
39. Petricoin E.F., Hackett J.L., Lesko L.J., Puri R.K., Gutman S.I., Chumakov K., Woodcock J., Feigal D.W., Zoon K.C., Sistare F.D. Medical applications of microarray technologies: a regulatory science perspective. Nat. Genet. 2002, 32:474-479. (Suppl.).
40. Lee W.G., Kim Y.G., Chung B.G., Demirci U., Khademhosseini A. Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv. Drug Deliv. Rev. 2010, 62:449-457.
41. Dutse S.W., Yusof N.A. Microfluidics-based lab-on-chip systems in DNA-based biosensing: an overview. Sensors 2011, 11:5754-5768.
42. Zhang C., Xing D. Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends. Nucleic Acids Res. 2007, 35:4223-4237.
43. Zhang C., Xu J., Ma W., Zheng W. PCR microfluidic devices for DNA amplification. Biotechnol. Adv. 2006, 24:243-284.
44. Chin C.D., Linder V., Sia S.K. Commercialization of microfluidic point-of-care diagnostic devices. Lab Chip 2012, 12:2118-2134.
45. Bianchessi M., Burgarella S., Cereda M. Point-of-care systems for rapid DNA quantification in oncology. Tumori 2008, 94:216-225.
46. Teo J., Di Pietro P., San Biagio F., Capozzoli M., Deng Y.M., Barr I., Caldwell N., Ong K.L., Sato M., Tan R., Lin R. VereFlu: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology. Arch. Virol. 2011, 156:1371-1378.
47. Caliendo A.M. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin. Infect. Dis. 2011, 52:S326-S330.
48. Langley M.R., Booker J.K., Evans J.P., McLeod H.L., Weck K.E. Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms. J. Mol. Diagn. 2009, 11:216-225.
49. Vairavan R. AutoGenomics, Inc. Pharmacogenomics 2004, 5:585-588.
50. Spizz G., Young L., Yasmin R., Chen Z., Lee T., Mahoney D., Zhang X., Mouchka G., Thomas B., Honey W., Roswech T., McGuire C., Montagna R., Zhou P. Rheonix CARD((R)) technology: an innovative and fully automated molecular diagnostic device. Point Care 2012, 11:42-51.
51. Ginocchio C.C. Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens. Clin. Infect. Dis. 2011, 52:S312-S325.
52. Storhoff J.J., Lucas A.D., Garimella V., Bao Y.P., Muller U.R. Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes. Nat. Biotechnol. 2004, 22:883-887.
53. Chae H., Kim M., Koh Y.S., Hwang B.H., Kang M.K., Kim Y., Park H.I., Chang K. Feasibility of a microarray-based point-of-care CYP2C19 genotyping test for predicting clopidogrel on-treatment platelet reactivity. BioMed. Res. Int. 2013, 2013:154073.
54. Alby K., Popowitch E.B., Miller M.B. Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses. J. Clin. Microbiol. 2013, 51:352-353.
55. Carroll K.C., Buchan B.W., Tan S., Stamper P.D., Riebe K.M., Pancholi P., Kelly C., Rao A., Fader R., Cavagnolo R., Watson W., Goering R.V., Trevino E.A., Weissfeld A.S., Ledeboer N.A. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay. J. Clin. Microbiol. 2013, 51:4120-4125.
56. Foglieni B., Brisci A., San Biagio F., Di Pietro P., Petralia S., Conoci S., Ferrari M., Cremonesi L. Integrated PCR amplification and detection processes on a Lab-on-Chip platform: a new advanced solution for molecular diagnostics. Clin. Chem. Lab. Med. 2010, 48:329-336.
57. Pernagallo S., Ventimiglia G., Cavalluzzo C., Alessi E., Ilyine H., Bradley M., Diaz-Mochon J.J. Novel biochip platform for nucleic acid analysis. Sensors 2012, 12:8100-8111.
58. Consolandi C., Severgnini M., Frosini A., Caramenti G., De Fazio M., Ferrara F., Zocco A., Fischetti A., Palmieri M., De Bellis G. Polymerase chain reaction of 2-kb cyanobacterial gene and human anti-alpha1-chymotrypsin gene from genomic DNA on the In-Check single-use microfabricated silicon chip. Anal. Biochem. 2006, 353:191-197.
59. Ventimiglia G., Petralia S. Recent advances in DNA microarray technology: an overview on production strategies and detection methods. BioNanoScience 2013, 3:428-450.
60. Petralia S., Verardo R., Klaric E., Cavallaro S., Alessi E., Schneider C. In-Check system: a highly integrated silicon Lab-on-Chip for sample preparation, PCR amplification and microarray detection of nucleic acids directly from biological samples. Sensors Actuators B Chem. 2013, 187:99-105.
61. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 1996, 6:986-994.
62. Schmittgen T., Lee E., Jiang J. High-throughput real-time pcr. Molecular Beacons: Signalling Nucleic Acid Probes, Methods, and Protocols 2008, 89-98. Humana Press. A. Marx, O. Seitz (Eds.).
63. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 2000, 25:169-193.
64. Hassibi A., Vikalo H., Riechmann J.L., Hassibi B. Real-time DNA microarray analysis. Nucleic Acids Res. 2009, 37:e132.
65. Hassibi A., Vikalo H., Riechmann J.L., Hassibi B. FRET-based real-time DNA microarrays. Methods Mol. Biol. 2012, 815:147-159.
66. Rao A.N., Rodesch C.K., Grainger D.W. Real-time fluorescent image analysis of DNA spot hybridization kinetics to assess microarray spot heterogeneity. Anal. Chem. 2012, 84:9379-9387.
67. Chagovetz A., Blair S. Real-time DNA microarrays: reality check. Biochem. Soc. Trans. 2009, 37:471-475.
68. Stimpson D.I., Hoijer J.V., Hsieh W.T., Jou C., Gordon J., Theriault T., Gamble R., Baldeschwieler J.D. Real-time detection of DNA hybridization and melting on oligonucleotide arrays by using optical wave guides. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:6379-6383.